“By bringing Dhaka into this initiative, we will be better able to prevent, identify and treat tuberculosis and help save lives," said U.S. Ambassador to Bangladesh Marcia Bernicat during the October 28 event in the country's capital city.
Partners In Health, Interactive Research and Development and the Zero TB Initiative welcome the release of interim results from STREAM Stage 1 clinical trial, which was conducted to study a new treatment regimen for multidrug-resistant tuberculosis (MDR-TB).
Defeating TB, which has reclaimed its titled as the leading killer of adults among all infectious diseases, requires perseverance and innovation. Dr. Farmer looks at the problem and solutions in this piece in the New York Times.
Representatives from 40 of the leading institutions working in TB and Global Health delivered a letter to WHO Director-General Dr Margaret Chan requesting inclusion of mycobacterium tuberculosis in the WHO's Global Priority List of antibiotic-resistant bacteria to guide research, discovery and development of new antibiotics.
Officials of the state health department, Indian Council of Medical Research (ICMR), World Health Organization and NGOs met at the state secretariat to finalize plans to detect cases and initiate treatment at an early stage.
The Stop TB Partnership Executive Committee approves recommendations from the TB REACH Project Review Committee for $16 million in new funding to implement and scale up innovative projects aimed at improving TB detection and care services.
To help accelerate the response to the TB epidemic, the Stop TB Partnership, the Department of Global Health and Social Medicine at Harvard Medical School, Advance Access & Delivery (AA&D), and Interactive Research and Development (IRD) have come together to launch the Zero TB Initiative to support cities, districts, and islands that are committed to achieving a rapid reduction in the number of people suffering from TB.